Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
Sud
Bhanu
B
Infectious Diseases Section, P.O. Box 26901, WP 1160, Oklahoma City, OK 73190, USA. Michelle-Salvaggio@OUHSC.edu
Salvaggio
Michelle
M
Greenfield
Ronald
R
Greenfield
Ronald A
RA
Bronze
Michael S
MS
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002701:Chloramphenicol / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D008795:Metronidazole / Q000494:pharmacology* / Q000627:therapeutic use; D009574:Nitro Compounds; D009582:Nitrofurantoin / Q000494:pharmacology* / Q000627:therapeutic use; D012294:Rifamycins / Q000494:pharmacology* / Q000627:therapeutic use; D000078262:Rifaximin; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use; D014011:Tinidazole / Q000494:pharmacology* / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D009574:Nitro Compounds; D012294:Rifamycins; D013844:Thiazoles; D014011:Tinidazole; D008795:Metronidazole; D002701:Chloramphenicol; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009582:Nitrofurantoin; D000078262:Rifaximin; C041747:nitazoxanide